Literature DB >> 16435566

The effects of gender and menopause on serum lidocaine levels in smokers.

Sermin Oztekin1, Omur Mavioglu, Zahide Elar, Hulya Guven, Sule Kalkan, Tugba Gurpinar.   

Abstract

It has been established that human cytochrome P450 (CYP) enzymatic activity is affected by gender, or by hormonal factors such as the menopause in women. Gender differences have a more pronounced effect on cytochrome (CYP) 3A4 isoenzyme activity, whereas cytochrome (CYP) 1A2 isoenzyme activity is mainly induced by chronic smoking. Lidocaine is frequently used in the treatment of hemodynamic changes following laryngoscopy and tracheal intubation during general anesthesia, and is metabolized by CYP3A4 and CYP1A2 isoenzymes in the liver. The aim of this study was investigate the effects of gender and menopause on serum lidocaine levels in smokers under general anesthesia. Six men, six premenopausal women and six postmenopausal women were enrolled in the study and received i.v. lidocaine (1 mg/kg) 1 minute before they underwent general anesthesia. Serum lidocaine concentrations were measured using the EMIT method at 1, 5, 10, 20, 40 and 60 minutes post-administration. Statistical analyses were performed using the Mann-Whitney U-test. No statistically significant differences were found regarding the area under curve (AUC(0-60) microg/mL/min), elimination half-life (t1/2 [min]) of lidocaine and in the measured levels of serum lidocaine at any time point between the study groups (p > 0.05). These results suggest that gender and menopause may have no significant effect on serum lidocaine levels in smokers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16435566     DOI: 10.1007/BF03190625

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  17 in total

1.  Effect of age and gender on the activity of human hepatic CYP3A.

Authors:  C M Hunt; W R Westerkam; G M Stave
Journal:  Biochem Pharmacol       Date:  1992-07-22       Impact factor: 5.858

2.  Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.

Authors:  S Imaoka; K Enomoto; Y Oda; A Asada; M Fujimori; T Shimada; S Fujita; F P Guengerich; Y Funae
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

3.  Impairment of prednisolone disposition in women taking oral contraceptives or conjugated estrogens.

Authors:  L E Gustavson; U F Legler; L Z Benet
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

Review 4.  How important are gender differences in pharmacokinetics?

Authors:  Bernd Meibohm; Ingrid Beierle; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Gender-related differences in pharmacokinetics and their clinical significance.

Authors:  E Tanaka
Journal:  J Clin Pharm Ther       Date:  1999-10       Impact factor: 2.512

6.  Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.

Authors:  H Y Lane; Y C Chang; W H Chang; S K Lin; Y T Tseng; M W Jann
Journal:  J Clin Psychiatry       Date:  1999-01       Impact factor: 4.384

7.  Differences in cardiovascular response to airway stimulation at different sites and blockade of the responses by lidocaine.

Authors:  Y Hamaya; S Dohi
Journal:  Anesthesiology       Date:  2000-07       Impact factor: 7.892

8.  Intravenous lidocaine as a suppressant of coughing during tracheal intubation in elderly patients.

Authors:  H Yukioka; M Hayashi; T Terai; M Fujimori
Journal:  Anesth Analg       Date:  1993-08       Impact factor: 5.108

9.  Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.

Authors:  M V Relling; J S Lin; G D Ayers; W E Evans
Journal:  Clin Pharmacol Ther       Date:  1992-12       Impact factor: 6.875

10.  The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics.

Authors:  R Z Harris; S M Tsunoda; P Mroczkowski; H Wong; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  1996-04       Impact factor: 6.875

View more
  1 in total

1.  Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine.

Authors:  Janne T Backman; Marika T Schröder; Pertti J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2007-10-23       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.